BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Rapamycin
,
rs3825942
,
PRKCA
,
Response to oxidative stress
,
Hepatitis
,
Retina
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
leukemia lymphoid
Summary
General Info
Curated Studies
Most Correlated Studies
Cancer Gene Census - mutations in cancer genes
GSK cancer cell line transcript profiling
OMIM - Malignant neoplasms
Diabetic Sera-induced transcriptional signatures in human leukemia cell lines
Acute myeloid leukemia cells treated with cell-specific IC50 concentrations of etoposide
Explore Curated Studies Results
Literature
Most Relevant Literature
Suppressing crucial oncogenes of leukemia initiator cells by major royal jelly protein 2 for mediati…
Acute lymphoid leukemia etiopathogenesis.
KCTD15 is overexpressed in human childhood B-cell acute lymphoid leukemia.
SHOC2 scaffold protein modulates daunorubicin-induced cell death through p53 modulation in lymphoid …
Impact of Genetics on Mature Lymphoid Leukemias and Lymphomas.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Preemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage A
Oshadi D & Oshadi R Combined With Salvage Chemotherapy for Relapsed Acute Myeloid Leukemia or Lympho…
The Incidence of Hepatitis B in Diffuse Large B‑Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positi…
Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or…
Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ